Front Row Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-205
Closed -$7K – 967
2020
Q2
$7K Sell
205
-22
-10% -$766 ﹤0.01% 557
2020
Q1
$8K Sell
227
-17
-7% -$754 0.01% 516
2019
Q4
$12K Hold
244
– – 0.01% 426
2019
Q3
$12K Hold
244
– – 0.01% 408
2019
Q2
$12K Hold
244
– – 0.01% 405
2019
Q1
$10K Sell
244
-33
-12% -$1.46K 0.01% 449
2018
Q4
$11K Buy
277
+120
+76% +$5.15K 0.01% 387
2018
Q3
$6K Buy
157
+40
+34% +$1.83K ﹤0.01% 521
2018
Q2
$5K Buy
117
+75
+179% +$3.5K ﹤0.01% 602
2018
Q1
$2K Buy
+42
New +$2.04K ﹤0.01% 793

Other funds holding MET

Front Row Advisors's MET Position: Q3 2020 in Review

Front Row Advisors sold out of MetLife (MET) in Q3 2020, closing a stake of 205 shares — an estimated $7K sold.

Front Row Advisors first reported a position in MET in Q1 2018 and held it in 10 quarters. The position peaked at $12K in Q4 2019. 961 funds tracked by Wall St. Rank hold MET as of Q3 2020.

  • Front Row Advisors reported no remaining MetLife position as of Q3 2020 after selling out during the quarter.
  • Front Row Advisors sold 205 MetLife shares in Q3 2020, an estimated $7K.
  • Front Row Advisors first reported a position in MetLife in Q1 2018 and held it in 10 quarters.
  • Front Row Advisors's MetLife position peaked at $12K in Q4 2019.
  • 961 funds tracked by Wall St. Rank held MetLife as of Q3 2020.

Based on Front Row Advisors's 13F filing for Q3 2020, filed 30 Nov 2020.